ARC Desk

Diabetes Management Market Overview, SWOT Analysis, Applications, Trends and Forecast 2018-2026

Lehdistötiedote   •   Syys 26, 2019 09:27 EEST

The latest research report on "Diabetes Management Market" added by Acumen Research and Consulting, presents a detailed analysis concerning market share, market valuations, revenue estimation, SWOT analysis, and regional spectrum of the business. The report further highlights key challenges and growth prospects of the market, while examining the business outlook comprising expansion strategies implemented by market leaders.

The report published by ARC provides rational insights along with historical and forecast data that aids in better understanding of the global scenario of Diabetes Management Market. The report provides a comprehensive analysis of the factors that are expected to drive and restrict the growth of the market. It also provides the detailed overview of the opportunities that are present in the market along with the current trends observed in the target market. The report includes a complete study of quantitative analysis of the industry for the period of 8 years in order to assist players to take advantage of the report. The report includes widespread analysis of the key segments of the industry that help for better understanding of the current trends and opportunities in the global Diabetes Management Market.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/878

The Porters Five Forces analysis is included in the report, provides insights on the overall scenario from buyers and suppliers point-of-view. The regulatory compliances provide insight of the various government rules and regulations on various products and services and the way it affects the various end use industry.

Scope of the Diabetes Management Market Report:

The study provides a decisive view of the Diabetes Management Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. It also provides country wise segmentation and the factors that are driving the regional growth.

The report cover the major players operating in the target market along with the key strategies adopted in order to get a competitive edge against the competitors which provides a competitive outlook of the industry. The report provides a competitive landscape that includes insights of the positioning of players on global level through mapping the business and product offering strength.

Regional Overview

Regionally, the technology for diabetes management market is segmented into North America, Europe, Asia Pacific and Latin America, Middle East & Africa.

North America is expected to dominate the technology for diabetes management market owing to the presence of huge patient pool, advancement in technology, and high spending on healthcare. According to WHO, 9.2% of the American population were suffering from diabetes in 2015. Additionally, presence of a huge number of players and increasing government support will fuel the growth of the market. Europe accounts for the second leading market in the forecast period followed by the Asia Pacific. Presences of huge investment in European region, huge government support, and well developed economies have driven the growth of the European market.

Asia Pacific technology for diabetes management market expected to be the fastest growth during the forecast period of 2016—2026. The growth is majorly attributed due to presence of huge diabetic and obese patients of the region. According to the International Diabetes Federation (IDF), in 2016, approximately 60% of total global diabetic population was present in Asia of which over 114 million are in China alone. Moreover, increasing government support and increasing per capita income have fueled the growth of the Asia Pacific market. LAMEA region is expecting a steady growth during the forecast period 2018—2026.

Report Coverage

Market Technology for Diabetes Management Market
Analysis Period 2015 – 2026
Historic Data 2015 – 2016
Base Year 2017
Forecast Data 2018 – 2026
Market Stratification Technology, Geography
Regional Scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)
Report Coverage Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis, Player Profiling, Value Chain Analysis

Market Segmentation:

Market By Technology

  • Glucose Test Strips
  • Digital Health / Digital Therapeutics
  • Insulin Pumps
  • Continuous Glucose Monitoring (CGM)
  • Insulin Pens
  • Side Effect Management & Diagnosis
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Market Participants / Key Players:

Some of the major key players in the market are Abbott, Animas, DexCom, Medtronic, Roche, Accu-Chek, Eli Lilly, Bayer, LifeScan, Novo Nordisk, Sanofi-aventis, Merck, Takeda Pharmaceuticals, Novartis, and Bristol-Myers Squibb.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

  • What is the overall structure of the market?
  • What was the historical value and what is the forecasted value of the market?
  • What are the key product level trends in the market?
  • What are the market level trends in the market?
  • Which of the market players are leading and what are their key differential strategies to retain their stronghold?
  • Which are the most lucrative regions in the market space?

VIEW FULL RESEARCH REPORT@ https://www.acumenresearchandconsulting.com/diabetes-management-market

TABLE OF CONTENT 

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope

1.1.1. Definition of Diabetes Management

1.1.2. Market Segmentation

1.1.3. List of Abbreviations

1.2. Summary

1.2.1. Market Snapshot

1.2.2. Diabetes Management Market By Technology

1.2.2.1. Global Diabetes Management Market Revenue and Growth Rate Comparison By Technology (2015-2026)

1.2.2.2. Global Diabetes Management Market Revenue Share By Technology in 2017

1.2.2.3. Glucose Test Strips

1.2.2.4. Digital Health / Digital Therapeutics

1.2.2.5. Insulin Pumps

1.2.2.6. Continuous Glucose Monitoring (CGM)

1.2.2.7. Insulin Pens

1.2.2.8. Side Effect Management & Diagnosis

1.2.2.9. Others

1.2.3. Diabetes Management Market by Geography

1.2.3.1. Global Diabetes Management Market Revenue and Growth Rate Comparison by Geography (2015-2026)

1.2.3.2. North America Diabetes Management Market Revenue and Growth Rate (2015-2026)

1.2.3.3. Europe Diabetes Management Market Revenue and Growth Rate (2015-2026)

1.2.3.4. Asia-Pacific Diabetes Management Market Revenue and Growth Rate (2015-2026)

1.2.3.5. Latin America Diabetes Management Market Revenue and Growth Rate (2015-2026)

1.2.3.6. Middle East and Africa (MEA) Diabetes Management Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers

2.2. Restraints and Challenges

2.3. Growth Opportunities

2.4. Porter’s Five Forces Analysis

2.4.1. Bargaining Power of Suppliers

2.4.2. Bargaining Power of Buyers

2.4.3. Threat of Substitute

2.4.4. Threat of New Entrants

2.4.5. Degree of Competition

2.5. Value Chain Analysis

2.6. Cost Structure Analysis

2.6.1. Raw Material and Suppliers

2.6.2. Manufacturing Process Analysis

2.7. Regulatory Compliance

2.8. Competitive Landscape, 2017

2.8.1. Player Positioning Analysis

2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Diabetes Management Major Manufacturers in 2017

3.2. Manufacturing Plants Distribution of Global Diabetes Management Major Manufacturers in 2017

3.3. R&D Status and Technology Source of Global Diabetes Management Major Manufacturers in 2017

3.4. Raw Materials Sources Analysis of Global Diabetes Management Major Manufacturers in 2017

CHAPTER 4. DIABETES MANAGEMENT MARKET BY TECHNOLOGY

4.1. Global Diabetes Management Revenue By Technology

4.2. Glucose Test Strips

4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.3. Digital Health / Digital Therapeutics

4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.4. Insulin Pumps

4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.5. Continuous Glucose Monitoring (CGM)

4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.6. Insulin Pens

4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.7. Side Effect Management & Diagnosis

4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.8. Others

4.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

4.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NORTH AMERICA DIABETES MANAGEMENT MARKET BY COUNTRY

5.1. North America Diabetes Management Market Revenue and Growth Rate, 2015 - 2026 ($Million)

5.2. North America Diabetes Management Market Revenue Share Comparison, 2015 & 2026 (%)

5.3. U.S.

5.3.1. U.S. Diabetes Management Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

5.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

5.4. Canada

5.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

5.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

5.5. Mexico

5.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

5.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 6. EUROPE DIABETES MANAGEMENT MARKET BY COUNTRY

6.1. Europe Diabetes Management Market Revenue and Growth Rate, 2015 - 2026 ($Million)

6.2. Europe Diabetes Management Market Revenue Share Comparison, 2015 & 2026 (%)

6.3. UK

6.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

6.4. Germany

6.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

6.5. France

6.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

6.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

6.6. Spain

6.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

6.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

6.7. Rest of Europe

6.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

6.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC DIABETES MANAGEMENT MARKET BY COUNTRY

7.1. Asia-Pacific Diabetes Management Market Revenue and Growth Rate, 2015 - 2026 ($Million)

7.2. Asia-Pacific Diabetes Management Market Revenue Share Comparison, 2015 & 2026 (%)

7.3. China

7.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

7.4. Japan

7.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

7.5. India

7.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

7.6. Australia

7.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

7.7. South Korea

7.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

7.8. Rest of Asia-Pacific

7.8.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

7.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. LATIN AMERICA DIABETES MANAGEMENT MARKET BY COUNTRY

8.1. Latin America Diabetes Management Market Revenue and Growth Rate, 2015 - 2026 ($Million)

8.2. Latin America Diabetes Management Market Revenue Share Comparison, 2015 & 2026 (%)

8.3. Brazil

8.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

8.4. Argentina

8.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

8.5. Rest of Latin America

8.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. MIDDLE EAST DIABETES MANAGEMENT MARKET BY COUNTRY

9.1. Middle East Diabetes Management Market Revenue and Growth Rate, 2015 - 2026 ($Million)

9.2. Middle East Diabetes Management Market Revenue Share Comparison, 2015 & 2026 (%)

9.3. Saudi Arabia

9.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

9.4. UAE

9.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

9.5. Rest of Middle East

9.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. AFRICA DIABETES MANAGEMENT MARKET BY COUNTRY

10.1. Africa Diabetes Management Market Revenue and Growth Rate, 2015 - 2026 ($Million)

10.2. Africa Diabetes Management Market Revenue Share Comparison, 2015 & 2026 (%)

10.3. South Africa

10.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

10.4. Egypt

10.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

10.5. Rest of Africa

10.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. Abbott

11.1.1. Company Snapshot

11.1.2. Overview

11.1.3. Financial Overview

11.1.4. Product Portfolio

11.1.5. Key Developments

11.1.6. Strategies

11.2. Animas

11.2.1. Company Snapshot

11.2.2. Overview

11.2.3. Financial Overview

11.2.4. Product Portfolio

11.2.5. Key Developments

11.2.6. Strategies

11.3. DexCom

11.3.1. Company Snapshot

11.3.2. Overview

11.3.3. Financial Overview

11.3.4. Product Portfolio

11.3.5. Key Developments

11.3.6. Strategies

11.4. Medtronic

11.4.1. Company Snapshot

11.4.2. Overview

11.4.3. Financial Overview

11.4.4. Product Portfolio

11.4.5. Key Developments

11.4.6. Strategies

11.5. Roche

11.5.1. Company Snapshot

11.5.2. Overview

11.5.3. Financial Overview

11.5.4. Product Portfolio

11.5.5. Key Developments

11.5.6. Strategies

11.6. Accu-Chek

11.6.1. Company Snapshot

11.6.2. Overview

11.6.3. Financial Overview

11.6.4. Product Portfolio

11.6.5. Key Developments

11.6.6. Strategies

11.7. Eli Lilly

11.7.1. Company Snapshot

11.7.2. Overview

11.7.3. Financial Overview

11.7.4. Product Portfolio

11.7.5. Key Developments

11.7.6. Strategies

11.8. Bayer

11.8.1. Company Snapshot

11.8.2. Overview

11.8.3. Financial Overview

11.8.4. Product Portfolio

11.8.5. Key Developments

11.8.6. Strategies

11.9. LifeScan

11.9.1. Company Snapshot

11.9.2. Overview

11.9.3. Financial Overview

11.9.4. Product Portfolio

11.9.5. Key Developments

11.9.6. Strategies

11.10. Novo Nordisk

11.10.1. Company Snapshot

11.10.2. Overview

11.10.3. Financial Overview

11.10.4. Product Portfolio

11.10.5. Key Developments

11.10.6. Strategies

11.11. Sanofi-aventis

11.11.1. Company Snapshot

11.11.2. Overview

11.11.3. Financial Overview

11.11.4. Product Portfolio

11.11.5. Key Developments

11.11.6. Strategies

11.12. Merck

11.12.1. Company Snapshot

11.12.2. Overview

11.12.3. Financial Overview

11.12.4. Product Portfolio

11.12.5. Key Developments

11.12.6. Strategies

11.13. Takeda Pharmaceuticals

11.13.1. Company Snapshot

11.13.2. Overview

11.13.3. Financial Overview

11.13.4. Product Portfolio

11.13.5. Key Developments

11.13.6. Strategies

11.14. Novartis

11.14.1. Company Snapshot

11.14.2. Overview

11.14.3. Financial Overview

11.14.4. Product Portfolio

11.14.5. Key Developments

11.14.6. Strategies

11.15. Bristol-Myers Squibb

11.15.1. Company Snapshot

11.15.2. Overview

11.15.3. Financial Overview

11.15.4. Product Portfolio

11.15.5. Key Developments

11.15.6. Strategies

11.16. Others

11.16.1. Company Snapshot

11.16.2. Overview

11.16.3. Financial Overview

11.16.4. Product Portfolio

11.16.5. Key Developments

11.16.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology

12.1.1. Initial Data Search

12.1.2. Secondary Research

12.1.3. Primary Research

12.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/878

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.